Indian clinical practice consensus guidelines for the management of recurrent, persistent, or metastatic squamous cell carcinoma of head-and-neck – Update 2024

ABSTRACT Head-and-neck squamous cell carcinoma (HNSCC) remains a significant public health concern, particularly in India, where its incidence is disproportionately high due to risk factors such as tobacco and alcohol use. The updated guidelines for the management of HNSCC reflect a comprehensive review of current evidence and practices tailored to the Indian context. These emphasize a multidisciplinary approach and the integration of novel therapeutic modalities, including immune checkpoint inhibitors and metronomic chemotherapy. Enhanced diagnostic protocols and a focus on supportive care underscore the commitment to improving patient outcomes and quality of life. This update aims to provide healthcare professionals with clear, evidence-based recommendations that address the unique challenges faced by patients with HNSCC in India.

Authors

Institutions

Publication Details

Journal
Cancer Research Statistics and Treatment
Published
2025-10-01
DOI
https://doi.org/10.4103/crst.crst_111_25
Primary Topic
Head and Neck Cancer Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Indian clinical practice consensus guidelines for the management of recurrent, persistent, or metastatic squamous cell carcinoma of head-and-neck – Update 2024

Munish Gairola, Vijay Patil, Manish Singhal, Praveen Birur et al.
Cancer Research Statistics and Treatment
Head and Neck Cancer Studies
article

Indian clinical practice consensus guidelines for the management of recurrent, persistent, or metastatic squamous cell carcinoma of head-and-neck – Update 2024

Munish Gairola, Vijay Patil, Manish Singhal, Praveen Birur, HS Darling, Pankaj Chaturvedi, Moni Abraham Kuriakose, Abhishek Mahajan, Kumar Prabhash, Sumit Goyal, Vishal Rao, K. Govind Babu, Vanita Noronha, Goura Kishore Rath, Ashish Kaushal
article en

Abstract

ABSTRACT Head-and-neck squamous cell carcinoma (HNSCC) remains a significant public health concern, particularly in India, where its incidence is disproportionately high due to risk factors such as tobacco and alcohol use. The updated guidelines for the management of HNSCC reflect a comprehensive review of current evidence and practices tailored to the Indian context. These emphasize a multidisciplinary approach and the integration of novel therapeutic modalities, including immune checkpoint inhibitors and metronomic chemotherapy. Enhanced diagnostic protocols and a focus on supportive care underscore the commitment to improving patient outcomes and quality of life. This update aims to provide healthcare professionals with clear, evidence-based recommendations that address the unique challenges faced by patients with HNSCC in India.

Cancer Research Statistics and TreatmentVol. 8(Suppl 1)
Indraprastha Apollo Hospitals (IN), Homi Bhabha National Institute (IN), Tata Memorial Hospital (IN), P. D. Hinduja Hospital and Medical Research Centre (IN), Clatterbridge Cancer Centre NHS Foundation Trust (GB), Rajiv Gandhi Cancer Institute and Research Centre (IN), Mazumdar Shaw Medical Centre (IN), HCG Cancer Hospital (IN), KLE Academy of Higher Education and Research (IN), HCG Cancer Centre (IN), Command Hospital Air Force (IN), Advanced Centre for Treatment, Research and Education in Cancer (IN), All India Institute of Medical Sciences (IN)
Openalex Percentile: Top 62%
Head and Neck Cancer Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.